Patents Examined by Eric Winakur
-
Patent number: 10098577Abstract: Remanufactured medical sensors and methods for remanufacturing used medical sensors are provided. Such a remanufactured sensor may include certain components from a used medical sensor and certain new components. For example, a remanufactured regional oximetry sensor may include a padding layer, an emitter and a pair of detectors, a flexible circuit coupled to the emitter and detectors, and a patient-contacting adhesive layer. The flexible circuit, the emitter, the first detector, the second detector, or any combination thereof, are from a used medical sensor, and the padding layer, the patient-contacting adhesive layer, or a combination thereof, are new.Type: GrantFiled: October 7, 2015Date of Patent: October 16, 2018Assignee: COVIDIEN LPInventors: David P. Besko, Donald R. Sandmore
-
Patent number: 10092226Abstract: A mechanism for non-invasively monitoring blood characteristics of a subject is disclosed. To enable measurement of hemoglobin concentrations in a cost-effective way, a computational model is established that represents a relationship between a first variable indicative of total hemoglobin concentration and a set of variables that includes second variables indicative of light transmission through tissue and third variables indicative of concentration percentages of different hemoglobin species. In-vivo measurement signals are acquired from a subject and in-vivo values are determined for the second and third variables based on the in-vivo measurement signals. The first variable is then solved based on the in-vivo values of the second and third variables and the computational model.Type: GrantFiled: December 23, 2011Date of Patent: October 9, 2018Assignee: General Electric CompanyInventors: Matti Huiku, Katja Urpalainen
-
Patent number: 10092227Abstract: A handheld device measures all vital signs and some hemodynamic parameters from the human body and transmits measured information wirelessly to a web-based system, where the information can be analyzed by a clinician to help diagnose a patient. The system utilizes our discovery that bio-impedance signals used to determine vital signs and hemodynamic parameters can be measured over a conduction pathway extending from the patient's wrist to a location on their thoracic cavity, e.g. their chest or navel. The device's form factor can include re-usable electrode materials to reduce costs. Measurements made by the handheld device, which use the belly button as a ‘fiducial’ marker, facilitate consistent, daily measurements, thereby reducing positioning errors that reduce accuracy of standard impedance measurements. In this and other ways, the handheld device provides an effective tool for characterizing patients with chronic diseases, such as heart failure, renal disease, and hypertension.Type: GrantFiled: January 5, 2016Date of Patent: October 9, 2018Assignee: TOSENSE, INC.Inventors: Matthew Banet, Marshal Singh Dhillon, Susan Meeks Pede, Lauren Nicole Miller Hayward, Arthur Deptala, Jonas Dean Cochran
-
Patent number: 10092208Abstract: System and method of using electromagnetic radiation signals to non-invasively test a glucose level in a subject. During operation, an incident beam of Terahertz waves is generated and projected onto the surface of the eyeball, which is naturally reflected by a tear layer. The reflected Terahertz waves are detected and characterized to determine the reflection characteristics of the tear layer, e.g., an axial ratio of reflection coefficients in two polarization orientations. Provided with the determined axial ratio and according to a predetermined correlation among axial ratio, tear glucose level and blood glucose level, the current blood glucose level in the subject can be derived and presented to a user.Type: GrantFiled: July 24, 2015Date of Patent: October 9, 2018Assignee: ADVANTEST CORPORATIONInventor: Yang Shang
-
Patent number: 10092209Abstract: System and method of using electromagnetic radiation signals to non-invasively test a glucose level in a subject. During operation, an incident beam of Terahertz waves is generated and projected onto the surface of the eyeball, which is naturally reflected by a tear layer. The reflected Terahertz waves are detected and characterized to determine the reflection characteristics of the tear layer, e.g., an axial ratio of reflection coefficients in two polarization orientations. Provided with the determined axial ratio and according to a predetermined correlation among axial ratio, tear glucose level and blood glucose level, the current blood glucose level in the subject can be derived and presented to a user.Type: GrantFiled: July 24, 2015Date of Patent: October 9, 2018Assignee: ADVANTEST CORPORATIONInventor: Yang Shang
-
Patent number: 10092225Abstract: A system and method for measuring glucose levels in a user's blood without having to draw a blood sample. A wave energy source emits wave energy. A modified ceramic coaxial resonator is provided that receives the wave energy and produces a frequency oscillation. An opening is formed in a conductive layer surrounding the ceramic coaxial resonator. Skin tissue is pressed against the opening. The sample tissue alters the frequency oscillation created by the ceramic coaxial resonator. At least some of the altered frequency oscillation is indicative of blood glucose levels within the sample tissue.Type: GrantFiled: February 12, 2016Date of Patent: October 9, 2018Inventor: Sarijit S. Bharj
-
Patent number: 10092228Abstract: A wearable optical device is described for optically detecting parameters of interest within muscle, such as during physical activity or when at rest. The parameters of interest include oxygenation level and/or hemoglobin concentrations in some situations. The detected parameters, such as oxygenation level, may be used to assess physical performance, such as the extent to which the muscle is utilizing aerobic or anaerobic processes. Methods for determining the parameters of interest, such as oxygenation level, from the detected optical signals are also described, and feedback may be provided to a user.Type: GrantFiled: May 4, 2018Date of Patent: October 9, 2018Assignee: Dynometrics Inc.Inventors: Daniel Wiese, Alessandro Babini, Sebastian Trousil, Samuel Huberman, Stefan Kalchmair, Pamela G. Anderson
-
Patent number: 10092245Abstract: Methods and apparatus are presented for removing motion artifacts from physiological signals produced by a physiological sensor of a wearable device, wherein the physiological sensor includes at least one optical emitter and at least one optical detector. Light emitted by the at least one optical emitter that is scattered by a body of a subject wearing the device is detected, and a physiological information signal therefrom is produced via the at least one optical detector. Light emitted by the at least one optical emitter that is scattered by a light regulating region of the wearable device is detected, and a motion noise information signal is produced via the at least one optical detector. The physiological information signal and the motion noise information signal are processed via at least one processor associated with the wearable device to at least partially remove unwanted motion artifacts from the physiological information signal.Type: GrantFiled: June 16, 2015Date of Patent: October 9, 2018Assignee: Valencell, Inc.Inventors: Steven Francis LeBoeuf, Jesse Berkley Tucker, Michael Edward Aumer
-
Patent number: 10092249Abstract: A robust alarm system has an alarm controller adapted to input an alarm trigger and to generate at least one alarm drive signal in response. Alarm subsystems input the alarm drive signal and activate one or more of multiple alarms accordingly. A subsystem function signal provides feedback to the alarm controller as to alarm subsystem integrity. A malfunction indicator is output from the alarm controller in response to a failure within the alarm subsystems.Type: GrantFiled: March 30, 2015Date of Patent: October 9, 2018Assignee: Masimo CorporationInventors: Massi Joe E. Kiani, Mohamed Kheir Diab, Marcelo M. Lamego
-
Patent number: 10085656Abstract: A measurement device according to the present disclosure includes a light source which emits at least one kind of measurement light belonging to a predetermined wavelength band toward a measurement region formed of at least part of a living body, a detection unit in which a plurality of sensors is regularly arranged in a predetermined arrangement and which detects the measurement light emitted from the light source and passing through the living body with the plurality of sensors, and an analysis unit which performs analysis processing of specifying a measurement position for measuring information on pulsation along with activities of the living body from the measurement region based on a temporal change in an amount of light of the detected measurement light by use of a detection result detected by the detection unit.Type: GrantFiled: November 16, 2012Date of Patent: October 2, 2018Assignee: Sony CorporationInventor: Hideo Sato
-
Patent number: 10085658Abstract: The invention provides a body-worn system that continuously measures pulse oximetry and blood pressure, along with motion, posture, and activity level, from an ambulatory patient. The system features an oximetry probe that comfortably clips to the base of the patient's thumb, thereby freeing up their fingers for conventional activities in a hospital, such as reading and eating. The probe secures to the thumb and measures time-dependent signals corresponding to LEDs operating near 660 and 905 nm. Analog versions of these signals pass through a low-profile cable to a wrist-worn transceiver that encloses a processing unit. Also within the wrist-worn transceiver is an accelerometer, a wireless system that sends information through a network to a remote receiver, e.g. a computer located in a central nursing station.Type: GrantFiled: November 27, 2013Date of Patent: October 2, 2018Assignee: SOTERA WIRELESS, INC.Inventors: Jim Moon, Devin McCombie, Marshal Dhillon, Matt Banet
-
Patent number: 10085682Abstract: Provided is an apparatus and method of measuring stress. The apparatus includes: a light source configured to emit light to the subject; a sensor configured to measure light reflected from the subject; a data extractor configured to obtain, from the reflected light, data that indicates at least one object material included in the subject; and a data processor configured to generate information about the stress of the subject based on a correlation between the obtained data and a reference value of stress.Type: GrantFiled: July 7, 2015Date of Patent: October 2, 2018Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Joonhyung Lee, Sangkyu Kim, Seongho Cho
-
Patent number: 10085657Abstract: The invention provides a body-worn system that continuously measures pulse oximetry and blood pressure, along with motion, posture, and activity level, from an ambulatory patient. The system features an oximetry probe that comfortably clips to the base of the patient's thumb, thereby freeing up their fingers for conventional activities in a hospital, such as reading and eating. The probe secures to the thumb and measures time-dependent signals corresponding to LEDs operating near 660 and 905 nm. Analog versions of these signals pass through a low-profile cable to a wrist-worn transceiver that encloses a processing unit. Also within the wrist-worn transceiver is an accelerometer, a wireless system that sends information through a network to a remote receiver, e.g. a computer located in a central nursing station.Type: GrantFiled: September 14, 2009Date of Patent: October 2, 2018Assignee: SOTERA WIRELESS, INC.Inventors: Jim Moon, Devin McCombie, Marshal Dhillon, Matt Banet
-
Patent number: 10080876Abstract: Described here are devices, systems, and kits for delivering substances to tissues. The devices generally include one or more chambers (102) and a reservoir (108) within each chamber. The reservoir may locally deliver a microdose amount of a substance to a target tissue. In some variations, a microdose amount is used in early human studies, e.g., before a phase I clinical trial, to evaluate the effect of the substance on a target tissue, or to obtain pharmacokinetic or metabolic data. In other variations, a microdose amount is used to locally treat a medical condition. In yet other variations, a microdose amount is used to locally deliver a contrast agent for a structural or functional imaging procedure. Methods for delivering and retrieving the devices from the target tissue are also described.Type: GrantFiled: August 20, 2009Date of Patent: September 25, 2018Assignee: Kibur Medical, Inc.Inventors: Robert I. Tepper, Russell Hirsch, Jason E. Fuller, Jessica L. Duda, Craig Muir, Jeffrey S. Ross, J. Christopher Flaherty
-
Patent number: 10080811Abstract: The present Invention relates to the monitoring of biological substances, such as non-invasive monitoring of such substances in animal, for examples biomarkers and metabolites. Specifically, the invention further relates to such monitoring using rare earth tagged marker compounds. The invention further relates to such monitoring using laser spectroscopy or Raman spectroscopy. The invention further relates to the use of such monitoring in disease states, such as stroke, neurological disorders and cardiovascular disorders.Type: GrantFiled: March 7, 2013Date of Patent: September 25, 2018Assignee: University of LeedsInventors: Sikha Saha, Gin Jose, Animesh Jha
-
Patent number: 10080514Abstract: A system including a sensor and a transceiver and configured to determine a concentration of an analyte in a medium of a living animal. The sensor may include first and second signal photodetectors and first and second reference photodetectors, which may each be covered by an associate filter. The first photodetector may receive light emitted from first and second grafts, respectively. The grafts may receive excitation light from one or more light sources. The transceiver may receive signals from the photodetectors of the sensor and may determine the analyte concentration based on the received signals.Type: GrantFiled: November 14, 2014Date of Patent: September 25, 2018Assignee: Senseonics, IncorporatedInventors: Jeremy Emken, Philip Huffstetler, Todd Whitehurst
-
Patent number: 10080504Abstract: Embodiments described herein generally relate to devices, methods and systems for determining blood oxygenation. By applying near infrared radiation of an appropriate wavelength to the tissue and determining the absorbance at a plurality of points where the distance between the source of the near infrared radiation and the detector are known, the oxygenation state of the hemoglobin can be determined based on position in a three dimensional space.Type: GrantFiled: November 10, 2014Date of Patent: September 25, 2018Assignees: University of Houston System, The Methodist HospitalInventors: Luca Pollonini, Scott E. Parazynski, Kiefer Forseth
-
Patent number: 10076356Abstract: A subcutaneous access device has a skin attachment plate coated with an adhesive layer. The skin attachment plate is moveably linked by a retraction mechanism to a needle support with fixedly positioned needles. In the ready-to-use position the skin attachment plate is spaced away from the needle support and covers the fixedly positioned needles. Subcutaneous insertion of the needles is effected by attachment of the skin attachment plate with the adhesive layer to the skin and releasing the retraction mechanism, thus triggering the pulling of the attached skin with high velocity against the tip of the needles.Type: GrantFiled: April 8, 2013Date of Patent: September 18, 2018Assignee: PharmaSens AGInventors: Paul Hadvary, Hansjorg Tschirky
-
Patent number: 10076254Abstract: A wearable computing device includes an electro-optical sensor to translate received light into an electrical signal. During a first mode of operation of the wearable computing device, a physical parameter of a wearer of the wearable computing device is assessed from the electrical signal. During a second mode of operation of the wearable computing device, encoded communication data is extracted from the electrical signal.Type: GrantFiled: December 16, 2014Date of Patent: September 18, 2018Assignee: MICROSOFT TECHNOLOGY LICENSING, LLCInventors: Kevin Woo, Ceasar Barcenas de Leon, Vinod L. Hingorani, Erik Holverson
-
Patent number: 10064573Abstract: A sensor that may be used to detect the presence, amount, and/or concentration of an analyte in a medium within an animal. The sensor may include a sensor housing, an indicator element embedded within and/or covering at least a portion of the sensor housing, and a membrane over the indicator element. The membrane may reduce indicator element deterioration by preventing immune cells, such as white blood cells, from contacting the indicator element, substantially prevent transmission of light of at least a specified wavelength or range of wavelengths through the membrane, and/or permit the analyte to pass through to the indicator element. The membrane may be an opaque diffusion membrane. The sensor may include a foil. The foil may block light and/or reduce indicator element deterioration. The membrane may reduce oxidation of the indicator element.Type: GrantFiled: August 29, 2016Date of Patent: September 4, 2018Assignee: Senseonics, IncorporatedInventors: Jeremy Emken, Philip Huffstetler, Todd Whitehurst